Saturday, January 17, 2026
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home Tags APHEX

Tag: APHEX

Superbug News - CoronaVirus Watch List

Aphex BioCleanse (SNST) Making Serious Headlines.

Editor / Curator -
Aphex Biocleanse Systems
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Further Expands Distribution Channels.

Editor / Curator -
Dermaphex
Superbug News - CoronaVirus Watch List

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
Aphex
CoronaVirus

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
Aphex BioCleanse
Biotech News

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Photos: Aphex BioCleanse Systems.

Editor / Curator -
APHX, APHEX
Biotech News

Aphex BioCleanse Systems Inc, Expands Sanitizer Production at its New Manufacturing...

Editor / Curator -
12Page 1 of 2

Latest article

Y-Combinator | Top 10 Performing Portfolio Holdings

All News Editor / Curator -
Y Combinator, LLC (YC) is an US based technology startup accelerator and venture capital firm launched in March 2005, has incredibly been used to...

Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.

2025 Watch List Editor / Curator -
For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we...

Sekur Private Data (SKUR, SWISF) Inching Towards a Double!

Uncategorized Editor / Curator -
Sekur Private Data has been slowly working it's way higher, on a series of positive news events. Here are the headlines and short to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.